Cargando…
Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to their merits of high loading capacity, targeting delivery, reliable protection of agents, good biocompatibility, versatile structure modification and adjustable characteristics, such as size, surface charg...
Autores principales: | Wang, Ning, Chen, Minnan, Wang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111479/ https://www.ncbi.nlm.nih.gov/pubmed/31022431 http://dx.doi.org/10.1016/j.jconrel.2019.04.025 |
Ejemplares similares
-
Liposomes as Adjuvants and Vaccine Delivery Systems
por: Tretiakova, D. S., et al.
Publicado: (2022) -
Liposomal delivery system/adjuvant for tuberculosis vaccine
por: Moradi, Melika, et al.
Publicado: (2023) -
Licensed liposomal vaccines and adjuvants in the antigen delivery system
por: Krasnopolsky, Yuriy, et al.
Publicado: (2022) -
Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity
por: Wang, Ning, et al.
Publicado: (2020) -
Novel adjuvants and vaccine delivery systems
por: Morein, Bror, et al.
Publicado: (1996)